Monika Koch, Peter Banys – 30 December 2003

Ignazio R. Marino, Howard R. Doyle – 30 December 2003

Kyung‐Suk Suh, Seong Hoon Kim, Sang Beom Kim, Hyuk‐Joon Lee, Kuhn Uk Lee – 30 December 2003 – The goal of this study was to examine the safety and effectiveness of right lobectomy in living donor liver transplantation (LDLT). From January 1999 to January 2002, 100 cases of LDLT were performed at Seoul National University Hospital; 45 involved right lobectomy (RL), 17 involved extended left lobectomy (ELL), 37 involved left lateral segmentectomy (LLS), and 1 involved right posterior segmentectomy. The outcome of RL was compared with those of other types of hepatectomy.

James Neuberger – 30 December 2003

Ashok B. Jain, Bijan Eghtesad, Raman Venkataramanan, Paulo A. Fontes, Randeep Kashyap, Igor Dvorchik, A. Obaid Shakil, Leah Kingery, John J. Fung – 30 December 2003 – Hepatitis C virus (HCV) is currently the most common etiology for liver transplantation (LTx) in the United States. A significant number of patients develop recurrent HCV after LTx. Although there is no completely satisfactory treatment for recurrent HCV, a combination of interferon‐α (INF) and ribavirin remains the most widely used.

Wendy L. Frankel, Jason G. Tranovich, Laura Salter, Ginny Bumgardner, Peter Baker – 30 December 2003 – Macrovesicular steatosis (MaS), fibrosis, and inflammation have been associated with poor graft function after liver transplantation. We evaluated histological variation in livers to determine the optimal number of biopsies to estimate pathological characteristics in livers for transplantation. Specimens from autopsies performed during 3 months in 16‐ to 70‐years‐olds without known liver disease or drug and/or alcohol abuse were examined.

Hwan Y. Yoo, Ernesto Molmenti, Paul J. Thuluvath – 30 December 2003 – Previous studies have suggested that moderate donor liver steatosis is associated with an increased incidence of primary graft nonfunction (PGNF), delayed graft function, early graft loss, and retransplantation rates. The objective of our study was to determine the effect of donor body mass index (dBMI), after adjusting for other known confounding variables, on PGNF, early graft failure, retransplantation rate, and patient survival.

Dharmesh Kapoor, Doris N. Redhead, Peter C. Hayes, David J. Webb, Rajiv Jalan – 30 December 2003 – An acute increase in portal pressure or reduction in portal inflow has been shown to decrease renal plasma flow (RPF). The aim of the study was to evaluate regional and systemic hemodynamics after acute occlusion of a transjugular intrahepatic portosystemic stent‐shunt (TIPSS) and study the effect of the same on plasma endothelin (ET‐1) levels in the systemic circulation, renal vein, and hepatic vein. Sixteen patients attending for portography after previous TIPSS placement were studied.

Douglas W. Hanto, Annie H. Fecteau, Maria H. Alonso, John F. Valente, James F. Whiting – 30 December 2003 – ABO‐incompatible liver transplants (LTX) have been associated with a high risk of antibody‐mediated rejection, poor patient and graft survival, and a high risk of vascular thrombosis and ischemic bile duct complications.

Shawn D. St. Peter, David J. Post, Manuel I. Rodriguez‐Davalos, David D. Douglas, Adyr A. Moss, David C. Mulligan – 30 December 2003 – The goal of this report is to evaluate in a prospective randomized fashion the effect of flushing hepatic allografts with tacrolimus before transplantation. A prospective, double‐blinded, randomized trial was performed. Twenty patients receiving orthotopic liver transplants from October 2000 to October 2001 were randomized into two groups.